VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 404 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2016. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $366,000 | +15.1% | 15,734 | -21.1% | 0.01% | +25.0% |
| Q1 2018 | $318,000 | -46.7% | 19,950 | -30.5% | 0.01% | -46.7% |
| Q4 2017 | $597,000 | +43.9% | 28,725 | -0.7% | 0.02% | +36.4% |
| Q3 2017 | $415,000 | -13.4% | 28,925 | +4.3% | 0.01% | -15.4% |
| Q2 2017 | $479,000 | +26.4% | 27,727 | -19.4% | 0.01% | +18.2% |
| Q1 2017 | $379,000 | +10.2% | 34,407 | +44.8% | 0.01% | +10.0% |
| Q4 2016 | $344,000 | -53.3% | 23,760 | -20.8% | 0.01% | -52.4% |
| Q3 2016 | $737,000 | +86.1% | 29,995 | +52.6% | 0.02% | +75.0% |
| Q2 2016 | $396,000 | +55.3% | 19,651 | +102.4% | 0.01% | +50.0% |
| Q1 2016 | $255,000 | -76.0% | 9,707 | -7.2% | 0.01% | -75.0% |
| Q4 2015 | $1,062,000 | -13.9% | 10,455 | +51.2% | 0.03% | -13.5% |
| Q3 2015 | $1,233,000 | -81.5% | 6,914 | -76.9% | 0.04% | -80.0% |
| Q2 2015 | $6,652,000 | +26.4% | 29,945 | +13.0% | 0.18% | +29.4% |
| Q1 2015 | $5,264,000 | +994.4% | 26,501 | +688.7% | 0.14% | +921.4% |
| Q4 2014 | $481,000 | +7.6% | 3,360 | -1.5% | 0.01% | +7.7% |
| Q3 2014 | $447,000 | +1.4% | 3,410 | -2.4% | 0.01% | 0.0% |
| Q2 2014 | $441,000 | -58.0% | 3,494 | -56.1% | 0.01% | -58.1% |
| Q1 2014 | $1,050,000 | +113.4% | 7,968 | +90.1% | 0.03% | +93.8% |
| Q4 2013 | $492,000 | +70.8% | 4,192 | +51.8% | 0.02% | +60.0% |
| Q3 2013 | $288,000 | – | 2,761 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |